𝔖 Bobbio Scriptorium

✦ LIBER ✦

Joint United States of America (USA)/Japan study of UFT (uracil and tegafur) plus leucovorin (LV) in patients (pts) with metastatic colorectal cancer (CRC)

✍ Scribed by Hoff, P.M.; Loehrer, P.; Abbruzzese, J.L.; Ohtsu, A.; Hyodo, I.; Shirao, K.

Book ID: 123592863
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 197 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81627-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of biweekly iri

Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients

✍ Koji Okabayashi; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochia 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 392 KB

665 PUBLICATION Phase I/II study of 24-h

665 PUBLICATION Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients with metastatic colorectal cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Uracil/tegafur plus oral leucovorin does

Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer: Abstracted from: Douillard J, Hoff P, Skillings J et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002; 20: 3605–16.

✍ Borut Stabuc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB